105 Results

People

  1. Giralt
    Giralt
  2. Perales
    Perales
  3. Jakubowski
    Jakubowski
  4. Papadopoulos
    Papadopoulos
  5. O'Reilly
    O'Reilly
  6. Kernan
    Kernan
  7. Castro-Malaspina
    Castro-Malaspina
  8. Barker
    Barker
  9. Scaradavou
    Scaradavou
  10. Young
    Young

Groups

  1. Department of Medicine (72)
  2. Center for Hematologic Malignancies (65)
  3. Hematologic Malignancies, Division of (60)
  4. Bone Marrow Transplant (54)
  5. Pediatrics, Department of (52)
  6. Stem Cell Transplantation and Cellular Therapy Service (42)
  7. Survivorship Research (32)
  8. GSK Faculty (30)
  9. Tow Center for Developmental Oncology (TCDO) (29)
  10. Sloan Kettering Institute Faculty (22)
  1. "myeloablative conditioning"
Formats
  1. Journal Article (93)
  2. Research Letter (4)
  3. Editorial (3)
  4. Conference Paper (2)
  5. Guidelines (2)
  6. Review (1)
Groups
  1. Department of Medicine (72)
  2. Center for Hematologic Malignancies (65)
  3. Hematologic Malignancies, Division of (60)
  4. Bone Marrow Transplant (54)
  5. Pediatrics, Department of (52)
  6. Stem Cell Transplantation and Cellular Therapy Service (42)

More Groups

People
  1. Sergio Giralt (26)
  2. Miguel-Angel Perales (24)
  3. Juliet Barker (20)
  4. Ann Jakubowski (19)
  5. Esperanza Papadopoulos (18)
  6. Richard O'Reilly (16)

More People

Years
  1. 2025 (4)
  2. 2024 (5)
  3. 2023 (8)
  4. 2022 (5)
  5. 2021 (2)
  6. 2020 (9)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (33)
  2. Blood (13)
  3. Bone Marrow Transplantation (13)
  4. Pediatric Blood and Cancer (5)
  5. Transplantation and Cellular Therapy (5)
  6. Blood Advances (4)

More Publications

Publishers
  1. Elsevier Inc. (44)
  2. American Society of Hematology (17)
  3. Nature Publishing Group (16)
  4. Wiley Periodicals, Inc (5)
  5. John Wiley & Sons (4)
  6. Wiley Blackwell (4)

More Publishers

Results (105)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations
    Research Letter

    Kunvarjee, B.; Bidgoli, A.; Madan, R. P.; Vidal, E.; McAvoy, D.; Hosszu, K. K.; Scaradavou, A.; Spitzer, B. G.; Curran, K. J.; Cancio, M.; more...
    Journal of Allergy and Clinical Immunology (2023)

    Fulltext@MSK | Save
  • Cord blood power and the definition of success after BMT
    Editorial

    Boelens, J. J.; Scaradavou, A.
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Tracking the evolution of therapy-related myeloid neoplasms using chemotherapy signatures
    Journal Article

    Diamond, B.; Ziccheddu, B.; Maclachlan, K.; Taylor, J.; Boyle, E.; Ossa, J. A.; Jahn, J.; Affer, M.; Totiger, T. M.; Coffey, D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Survival of TP53-mutated acute myeloid leukemia patients receiving allogeneic stem cell transplantation after first induction or salvage therapy: Results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
    Journal Article

    Badar, T.; Atallah, E.; Shallis, R.; Saliba, A. N.; Patel, A.; Bewersdorf, J. P.; Grenet, J.; Stahl, M.; Duvall, A.; Burkart, M.; more...
    Leukemia (2023)

    Fulltext@MSK | Save
  • Transplant for non-malignant disorders: An International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering
    Guidelines

    Klein, O. R.; Bonfim, C.; Abraham, A.; Ruggeri, A.; Purtill, D.; Cohen, S.; Wynn, R.; Russell, A.; Sharma, A.; Ciccocioppo, R.; more...
    Cytotherapy (2023)

    Fulltext@MSK | Save
  • Three-year outcomes in recipients of mismatched unrelated bone marrow donor transplants using post-transplantation cyclophosphamide: Follow-up from a national marrow donor program-sponsored prospective clinical trial
    Journal Article

    Shaw, B. E.; Jimenez-Jimenez, A. M.; Burns, L. J.; Logan, B. R.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
    Transplantation and Cellular Therapy (2023)

    Fulltext@MSK | Save
  • Safety and efficacy of combinatorial therapy utilizing myeloablative conditioning and autologous stem cell transplantation, targeted immunotherapy, and reduced intensity conditioning and allogeneic stem cell transplantation in children, adolescents, and young adults with relapsed/refractory mature B-cell non-Hodgkin lymphoma
    Research Letter

    Gardenswartz, A.; Mehta, B.; El-Mallawany, N. K.; van de Ven, C.; Hochberg, J.; Flower, A.; Morris, E.; Harrison, L.; Chu, Y.; Basso, J.; more...
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Preservation of the fecal microbiome is associated with reduced severity of graft-versus-host disease
    Journal Article

    Burgos da Silva, M.; Ponce, D. M.; Dai, A.; Devlin, S. M.; Gomes, A. L. C.; Moore, G.; Slingerland, J.; Shouval, R.; Armijo, G. K.; DeWolf, S.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Impact of omitting post-transplant minidose-methotrexate doses in allogeneic hematopoietic cell transplantation
    Journal Article

    Lin, A.; Brown, S.; Maloy, M.; Ruiz, J. D.; Devlin, S.; DeRespiris, L.; Proli, A.; Jakubowski, A. A.; Papadopoulos, E. B.; Sauter, C. S.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • CD34+ -selected hematopoietic stem cell transplant conditioned with a myeloablative regimen in patients with advanced myelofibrosis
    Journal Article

    Nawas, M. T.; Lee, J. O.; Flynn, J.; Maloy, M.; Jakubowski, A. A.; Papadopoulos, E. B.; Cho, C.; Ponce, D. M.; Sauter, C. S.; Perales, M. A.; more...
    Bone Marrow Transplantation (2022)

    Fulltext@MSK | Save